Despite the emergence of anti-vascular endothelial growth factor (VEGF) agents to treat wet AMD, there are currently no therapies available to prevent the development of dry AMD aside from nutritional supplementation (AREDS formulation) (Age-Related Eye Disease Study Research Group, 2001). The gene discussed is VEGFA; the disease is wet macular degeneration.